Wenlang Fu

Person

Milford, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antiviral oxime phosphoramide compounds
- Patent number 10,450,335
- Issue date Oct 22, 2019
- Merck Sharp & Dohme Corp.
- Wenlang Fu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for rapidly evaluating performance of short interfering RNA...
- Patent number 9,512,426
- Issue date Dec 6, 2016
- SIRNA Therapeutics, Inc.
- Gabor Butora
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors
- Patent number 9,040,691
- Issue date May 26, 2015
- Bayer Intellectual Property GmbH
- Jürgen Klar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for rapidly evaluating performance of short interfering RNA...
- Patent number 8,877,439
- Issue date Nov 4, 2014
- SIRNA Therapeutics, Inc.
- Gabor Butora
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pyrrolotriazine derivatives useful for treating hyper-proliferative...
- Patent number 8,338,595
- Issue date Dec 25, 2012
- Bayer HealthCare LLC
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine derivatives for treatment of hyperproliferative disorders
- Patent number 7,678,804
- Issue date Mar 16, 2010
- Bayer HealthCare LLC
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine derivatives for treatment of hyperproliferative disorders
- Patent number 7,582,646
- Issue date Sep 1, 2009
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
Information Patent Grant
Pyrimidine derivatives for treatment of hyperproliferative disorders
- Patent number 7,582,645
- Issue date Sep 1, 2009
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine derivatives useful for treating hyper-proliferative...
- Patent number 7,563,791
- Issue date Jul 21, 2009
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FACTOR XI ACTIVATION INHIBITORS
- Publication number 20230147170
- Publication date May 11, 2023
- Merck Sharp & Dohme LLC
- Jacqueline D. Hicks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR XI ACTIVATION INHIBITORS
- Publication number 20220235033
- Publication date Jul 28, 2022
- MERCK SHARP & DOHME CORP.
- Jacqueline D. Hicks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS
- Publication number 20180362563
- Publication date Dec 20, 2018
- MERCK SHARP & DOHME CORP.
- Wenlang Fu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR RAPIDLY EVALUATING PERFORMANCE OF SHORT INTERFERING RNA...
- Publication number 20150132761
- Publication date May 14, 2015
- SIRNA THERAPEUTICS, INC.
- Gabor Butora
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS
- Publication number 20140256718
- Publication date Sep 11, 2014
- Bayer Intellectual Property GmbH
- Jürgen Klar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE...
- Publication number 20130225809
- Publication date Aug 29, 2013
- Bayer HealthCare LLC
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method For Rapidly Evaluating Performance Of Short Interfering RNA...
- Publication number 20120252027
- Publication date Oct 4, 2012
- Gabor Butora
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UREA COMPOUNDS USEFUL IN THE TREATMENT OF CANCER
- Publication number 20110195110
- Publication date Aug 11, 2011
- Roger Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
- Publication number 20110098301
- Publication date Apr 28, 2011
- Bayer HealthCare LLC
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE...
- Publication number 20100075958
- Publication date Mar 25, 2010
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISORDERS
- Publication number 20100075967
- Publication date Mar 25, 2010
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Derivatives
- Publication number 20090286785
- Publication date Nov 19, 2009
- Bayer Pharmaceuticals Corporation
- Dhanapalan Nagarathnam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Derivatives
- Publication number 20090258888
- Publication date Oct 15, 2009
- Bayer Pharmaceuticals Corporation
- Dhanapalan Nagarathnam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative...
- Publication number 20070208013
- Publication date Sep 6, 2007
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine derivatives for treatment of hyperproliferative disorders
- Publication number 20070117817
- Publication date May 24, 2007
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine derivatives for treatment of hyperproliferative disorders
- Publication number 20050277640
- Publication date Dec 15, 2005
- Bayer Pharmaceuticals Corporation
- Julie A. Dixon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors
- Publication number 20040267017
- Publication date Dec 30, 2004
- Donald E Bierer
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Antiviral oxime phosphoramide compounds

Method for rapidly evaluating performance of short interfering RNA...

Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors

Method for rapidly evaluating performance of short interfering RNA...

Pyrrolotriazine derivatives useful for treating hyper-proliferative...

Pyrimidine derivatives for treatment of hyperproliferative disorders

Pyrimidine derivatives for treatment of hyperproliferative disorders

Pyrimidine derivatives for treatment of hyperproliferative disorders

Pyrrolotriazine derivatives useful for treating hyper-proliferative...

Patents Applicationslast 30 patents

FACTOR XI ACTIVATION INHIBITORS

FACTOR XI ACTIVATION INHIBITORS

ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS

METHOD FOR RAPIDLY EVALUATING PERFORMANCE OF SHORT INTERFERING RNA...

HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS

PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE...

Method For Rapidly Evaluating Performance Of Short Interfering RNA...

UREA COMPOUNDS USEFUL IN THE TREATMENT OF CANCER

Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders

PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE...

PYRIMIDINE DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISORDERS

Pyrimidine Derivatives

Pyrimidine Derivatives

Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative...

Pyrimidine derivatives for treatment of hyperproliferative disorders

Pyrimidine derivatives for treatment of hyperproliferative disorders

3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors